Aug 6 (Reuters)-
Garna Biosciences Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2026 Jun 30, 2025 Dec 31, 2026
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 401 mln 251 mln 720 mln
(+59.8 pct) (-20.4 pct) (+24.4 pct)
Operating loss 954 mln loss 1.05 loss 2.03
Recurring loss 1.01 loss 1.06 loss 2.05
Net loss 1.04 loss 1.06 loss 2.09
EPS loss 53.13 yen loss 55.29 yen loss 108.95 yen
Ann Div NIL NIL
-Q2 div NIL
-Q4 div NIL NIL
NOTE - Garna Biosciences Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4572.T